Summarizing historical information on controls in clinical trials

样本量测定 临床试验 统计 样品(材料) 随机对照试验 计算机科学 计量经济学 医学 数学 内科学 色谱法 化学
作者
Beat Neuenschwander,Gorana Capkun-Niggli,Michael Branson,David J. Spiegelhalter
出处
期刊:Clinical Trials [SAGE]
卷期号:7 (1): 5-18 被引量:294
标识
DOI:10.1177/1740774509356002
摘要

Historical information is always relevant when designing clinical trials, but it might also be incorporated in the analysis. It seems appropriate to exploit past information on comparable control groups.Phase IV and proof-of-concept trials are used to discuss aspects of summarizing historical control data as prior information in a new trial. The importance of a fair assessment of the similarity of control parameters is emphasized.The methodology is meta-analytic-predictive. Heterogeneity of control parameters is expressed via the between-trial variation, which is the key parameter determining the prior effective sample size and its upper bound (prior maximum sample size).For a Phase IV trial (930 control patients in 11 historical trials) between-trial heterogeneity was fairly small, resulting in a prior effective sample size of approximately 90 patients. For a proof-of-concept trial (363 patients in four historical trials) heterogeneity was moderate to substantial, resulting in a prior effective sample size of approximately 20. For another proof-of-concept trial (14 patients in one historical trial), assuming substantial heterogeneity implied a prior effective sample size of 7. The prior effective sample size can only be large if the amount of historical data is large and between-trial heterogeneity is small. The prior effective sample size is bounded by the prior maximum sample size (ratio of within- to between-trial variance), irrespective of the amount of historical data.The meta-analytic-predictive approach assumes exchangeability of control parameters across trials. Due to the difficulty to quantify between-trial variability, sensitivity of conclusions regarding assumptions and type of inference should be assessed.The use of historical control information is a valuable option and may lead to more efficient clinical trials. The proposed approach is attractive for nonconfirmatory trials, but under certain circumstances extensions to the confirmatory setting could be envisaged as well.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
归尘发布了新的文献求助20
刚刚
刚刚
2秒前
2秒前
Yaxin发布了新的文献求助10
2秒前
高天雨完成签到 ,获得积分10
2秒前
文承龙完成签到,获得积分20
2秒前
勤恳怀梦完成签到,获得积分10
3秒前
3秒前
橙熟完成签到,获得积分10
3秒前
完美世界应助carol采纳,获得10
3秒前
sunrain完成签到,获得积分10
4秒前
5秒前
5秒前
simon完成签到 ,获得积分10
5秒前
MY发布了新的文献求助30
6秒前
7秒前
金桔希子完成签到,获得积分10
7秒前
7秒前
wanci应助CJHMer采纳,获得10
7秒前
可达完成签到,获得积分10
7秒前
又夏完成签到,获得积分10
8秒前
YCH完成签到,获得积分10
8秒前
uu完成签到,获得积分10
8秒前
海晨完成签到,获得积分10
8秒前
珈小羽完成签到,获得积分10
8秒前
W~舞完成签到,获得积分10
8秒前
淡淡翠曼发布了新的文献求助10
9秒前
9秒前
昊儿虫完成签到 ,获得积分10
9秒前
10秒前
10秒前
SY完成签到,获得积分10
11秒前
11秒前
11秒前
熙怡完成签到,获得积分10
11秒前
大胆的夏天完成签到,获得积分10
11秒前
LRISEM发布了新的文献求助30
11秒前
000完成签到,获得积分10
11秒前
FashionBoy应助海晨采纳,获得10
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Clinical Microbiology Procedures Handbook, Multi-Volume, 5th Edition 1000
扫描探针电化学 1000
Teaching Language in Context (Third Edition) 1000
Identifying dimensions of interest to support learning in disengaged students: the MINE project 1000
Introduction to Early Childhood Education 1000
List of 1,091 Public Pension Profiles by Region 941
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 物理化学 基因 遗传学 催化作用 冶金 量子力学 光电子学
热门帖子
关注 科研通微信公众号,转发送积分 5439032
求助须知:如何正确求助?哪些是违规求助? 4550108
关于积分的说明 14222413
捐赠科研通 4471061
什么是DOI,文献DOI怎么找? 2450182
邀请新用户注册赠送积分活动 1441117
关于科研通互助平台的介绍 1417735